Related Articles
Clinical outcome of immunotherapy with dendritic cell vaccine and cytokine‑induced killer cell therapy in hepatobiliary and pancreatic cancer
Enhanced antitumor effects and improved immune status of dendritic cell and cytokine‑induced killer cell infusion in advanced cancer patients
Effects of a gemcitabine plus platinum regimen combined with a dendritic cell-cytokine induced killer immunotherapy on recurrence and survival rate of non-small cell lung cancer patients
Dendritic cell-based vaccination in metastatic melanoma patients: Phase II clinical trial
Dendritic cell-activated cytokine-induced killer cell-mediated immunotherapy is safe and effective for cancer patients >65 years old